Search
for
Sort by
Research 601–630 of 656
- CD44 signaling in skin wound healing and regeneration
- Are Women with Polycystic Ovary Syndrome at Increased Risk of Alzheimer Disease? Lessons from Insulin Resistance, Tryptophan and Gonadotropin Disturbances and Their Link with Amyloid-Beta Aggregation
- Dermoscopy as an Auxiliary Tool in the Assessment of Malassezia Folliculitis: An Observational Study
- DESIGN OF A VALIDATED HPTLC METHODOLOGY FOR THE MEASUREMENT OF LINOLEIC AND OLEANOLIC ACID IN ECLIPTA ALBA
- Biosynthetic studies through feeding experiments in Eclipta prostrata (L.) L. hairy roots
- Post-Acute COVID-19 Sequelae – ‘COVID Long Hauler’
- Effects of α-Synuclein on the Lipid Phenotype of SZ95 Human Sebocytes: A Preliminary Study in the Context of Parkinson’s Disease
- The Mechanism and Research Progress of Skin Microbiota in Pathogenesis of Acne
- Exploring Acne Treatments: From Pathophysiological Mechanisms to Emerging Therapies
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Opposing impacts on healthspan and longevity by limiting dietary selenium in telomere dysfunctional mice
- Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata
- A phase 2a trial of brepocitinib for cicatricial alopecia
- Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study
- Under Development JAK Inhibitors for Dermatologic Diseases
- The significance of the apelinergic system in doxorubicin-induced cardiotoxicity
- Adverse Events in Isotretinoin Therapy: A Single-Arm Meta-Analysis
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Baricitinib for the Treatment of Alopecia Areata
- Glycerophospholipid Analysis of Eastern Red Bat (Lasiurus Borealis) Hair by Electrospray Ionization Tandem Mass Spectrometry
- Renal tubular dysfunction presenting as recurrent hypokalemic periodic quadriparesis in systemic lupus erythematosus
- Friend or foe: A systematic review of dupilumab and alopecia areata
- A review of Janus kinase inhibitor use in scarring alopecia
- Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata
- Dietary supplementation with L-glutamine enhances immunity and reduces heat stress in Hanwoo steers under heat stress conditions
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
- Mining and analysis of adverse event signals of isotretinoin based on the real-world data of FAERS database
- Duration of current alopecia areata episode predicts the effectiveness of baricitinib in Japanese patients with alopecia areata: a single-center retrospective study